Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06762665Recruiting
Radiology consultation for spine injections
This study tests whether a radiology consultation before a CT-guided spine injection helps patients with back or neck pain. If you have moderate to severe pain and are scheduled for this procedure, you may be eligible.
Montpellier, OccitnaieAges 18 years+ - NCT06762782RecruitingPhase 2
Lenvatinib after liver cancer surgery to prevent recurrence
This trial tests whether taking lenvatinib after liver cancer surgery can lower the chance of the cancer coming back. It is for people who have a high risk of recurrence and have recently had their liver tumor completely removed.
Nanjing, JiangsuAges 18–80 - NCT06763354Recruiting
Testing a new PET dye for bladder tumor imaging
This study tests a new type of PET scan dye to see how well it shows bladder tumors. It may help doctors get clearer images without needing extra biopsies.
ShanghaiAges 18–85 - NCT06763458Recruiting
Balloon angioplasty for minor unstable stroke with brain artery narrowing
This trial tests if balloon angioplasty (opening a narrowed artery with a tiny balloon) can help people who have had a minor stroke and are still having symptoms despite taking blood thinners.
ShenyangAges 18 years+ - NCT06763731RecruitingPhase 4
Optimizing the eye surface with Systane COMPLETE before cataract surgery
This study tests whether using Systane COMPLETE eye drops before cataract surgery can improve the eye surface in people with dry eye. If you have dry eye and are scheduled for cataract surgery, this trial may help improve your eye comfort and surgery outcomes.
Taipei, TaiwanAges 20–85 - NCT06763848Recruiting
Blood filtering for NMOSD attacks
This trial tests a blood filtering procedure called Protein A immunoadsorption for people having an acute episode of neuromyelitis optica spectrum disorder (NMOSD). It may help remove harmful antibodies from your blood and reduce symptoms.
Guangzhou, GuangdongAges 18–65 - NCT06764017RecruitingPhase 2
New combination therapy for elderly lymphoma unable to handle chemo
This trial tests a new treatment called CHiR for people 70 or older with a type of lymphoma (DLBCL) who are either too frail for standard chemo or choose not to have it. The study aims to see if this therapy can work as a gentler option.
Ningbo, ZhejiangAges 70–100 - NCT06764082Recruiting
Nutrition study for babies with biliary atresia
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
Wuhan, HubeiAges 1 day–3 months - NCT06764134Recruiting
Testing a new stapler to prevent pancreatic leaks after surgery
This trial tests a new type of stapler (AEON) used during surgery to remove the left part of the pancreas. The goal is to see if it helps reduce the risk of a leak from the pancreas after surgery.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06764225Recruiting
Low-Sodium Salt for Heart Failure Patients
This study tests whether using a low-sodium salt substitute can help people with heart failure live longer, avoid hospital visits, and feel better. It's for adults with a weakened heart pump who have a caregiver and eat home-cooked meals.
Beijing, Beijing MunicipalityAges 18–75 - NCT06765499Recruiting
Silkworm pupa powder for nutrition and frailty in motor neuron disease
This trial tests whether silkworm pupa powder can improve nutrition and reduce frailty in people with motor neuron disease (like ALS). It looks for volunteers who are frail, have a confirmed diagnosis, and are willing to provide blood, stool, and urine samples.
Hangzhou, ZhejiangAges 18–80 - NCT06765733RecruitingEarly Phase 1
Testing Aleeto for multiple system atrophy (MSA)
This trial tests a new treatment called Aleeto for people with a specific type of multiple system atrophy (MSA-P) who haven't responded well to standard Parkinson's medications. The goal is to see if Aleeto is safe and might help improve symptoms.
Beijing, Beijing MunicipalityAges 30–75 - NCT06766253Recruiting
Comparing three breathing tube devices for head-down laparoscopic surgery
This study is comparing three different breathing tube devices (GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask) for people having laparoscopic surgery while tilted head-down. The goal is to see which device works best and most safely.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06766422Recruiting
AI tool to better detect and predict brain aneurysm risk
This study uses artificial intelligence to help doctors better see and understand brain aneurysms from MRI or CT scans. It aims to improve how accurately aneurysms are found and whether they are stable or at risk of rupturing.
ShanghaiAges 18 years+ - NCT06766643RecruitingPhase 2
Stereotactic radiosurgery vs. radiofrequency ablation for liver cancer
This study compares two nonsurgical procedures for liver cancer: stereotactic radiosurgery (focused radiation) and radiofrequency ablation (heat therapy). It is for people whose tumor is in a tricky spot near major blood vessels or other structures, making surgery difficult, and who have not received prior treatment.
TianjinAges 18–75 - NCT06766916RecruitingPhase 2
Testing Crisugabalin for nerve pain after radiation
This trial tests a drug called Crisugabalin to see if it helps people with nerve pain caused by radiation treatment for head and neck cancer. The study aims to find a better way to manage this type of pain that does not go away.
Fuzhou, FujianAges 18 years+ - NCT06767150RecruitingPhase 4
Bone treatment after stopping denosumab for osteoporosis
This trial tests whether giving zoledronic acid (a bone-strengthening infusion) right after stopping denosumab can help prevent bone loss in women with post-menopausal osteoporosis. It may be a good option if you have finished at least 2 years of denosumab and your doctor says it's safe to stop.
AmiensAges 18 years+ - NCT06767293Recruiting
Parenting support for preterm children with behavior challenges
This trial tests a parenting program for caregivers of children born very preterm (before 32 weeks) who also have behavior problems. The program aims to help parents manage difficult behaviors and improve family well-being.
Cincinnati, OhioAges 3–8 - NCT06767345RecruitingPhase 4
Comparing two cholesterol medicines for plaque stabilization
This study compares two ways to lower cholesterol and stabilize artery plaque in people with coronary artery disease who are having a stent procedure. It tests whether a moderate statin plus ezetimibe works as well as a high-intensity statin alone for stabilizing plaque.
Seoul, SeoulAges 18 years+ - NCT06767488Recruiting
Breath test for mouth sores from radiation therapy
This study is testing a new breath test to see if it can detect and predict mouth sores caused by radiation therapy for head and neck tumors. The goal is to find a simple, non-invasive way to help doctors manage treatment side effects.
Guangzhou, GuangdongAges 18–75 - NCT06767774RecruitingPhase 4
Comparing two cholesterol treatments for heart patients
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
SeoulAges 18 years+ - NCT06768008Recruiting
Integrated care model for newborns with critical heart disease
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
BeijingAges 1 day–4 weeks - NCT06768138RecruitingPhase 3
Giving clot-busting medicine directly into the brain after successful blood flow restoration
This trial tests whether a clot-busting drug given directly into the brain artery can improve recovery after a major stroke caused by a blockage in the front part of the brain. The study is for people whose blood flow has already been successfully restored with standard treatments.
NancyAges 18 years+ - NCT06768528Recruiting
Galectin-3 and atrial fibrillation after heart bypass
This trial checks if a protein called galectin-3 can help predict who will develop an irregular heartbeat (atrial fibrillation) after coronary artery bypass surgery. It aims to find ways to better monitor and treat heart patients after surgery.
São Paulo, São PauloAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.